- ►annals.org [PDF] RB Devereux, B Dahlof, SE Kjeldsen, S Julius, … - Annals of internal medicine, 2003 - Am Coll Physicians Richard B. Devereux, MD; Björn Dahlöf, MD; Sverre E. Kjeldsen, MD; Stevo
Julius, MD; Peter Aurup, MD; Gareth Beevers, MD; Jonathan M. Edelman, MD; Ulf de
Faire, MD; Frej Fyhrquist, MD; Sigrid Helle Berg, BA; Hans Ibsen, MD; ... Cited by 44 - Related articles - All 6 versions
- ►anmco.it [PDF] B Dahlöf, RB Devereux, SE Kjeldsen, S Julius … - The Lancet, 2002 - Elsevier Blood pressure fell by 30·2/16·6 (SD 18·5/10·1) and 29·1/16·8 mm Hg
(19·2/10·1) in the losartan and atenolol groups, respectively. The primary
composite endpoint occurred in 508 losartan (23·8 per 1000 patient-years) ... Cited by 2729 - Related articles - BL Direct - All 20 versions
H Ibsen, OL Pedersen, B Dahlöf, SE Kjeldsen … - J Pediatr, 1999 - ugeskriftet.dk 2. Astrom E, Soderhall S. Beneficial effect of long term intravenous bisphos-
phonate treatment of osteogenesis imperfecta. Arch Dis Child 2002; 86: 356-64.
3. Glorieux FH. The use of bisphosphonates in children with osteogenesis ... Related articles - View as HTML - BL Direct - All 8 versions
- ►adisonline.com [PDF] MD Moen, AJ Wagstaff - Drugs, 2005 - ingentaconnect.com 0012-6667/05/0018-2657/$39.95/0 2005 Adis Data Information BV. All rights
reserved. ... A Review of its Use in Stroke Risk Reduction in Patients with
Hypertension and Left Ventricular Hypertrophy Cited by 17 - Related articles - BL Direct - All 7 versions
M Reims, S Oparil, E KJELDSEN, B Devereux, S … - Blood pressure, 2004 - informahealthcare.com From the 1Ullevaal University Hospital, Oslo, Norway, 2University of Alabama,
Birmingham, Alabama, USA, 3University of Michigan Hospital, Ann Arbor, Michigan,
USA, 4Cornell Medical Center, New York, USA, 5Merck & Co. Inc., Horsham, ... Cited by 9 - Related articles - All 9 versions
[CITATION] Helsinki Heart Study
JK Huttunen, MH Frick, OP Heinonen, P … - New perspectives in the prevention of coronary heart …, 1988 Cited by 8 - Related articles
MH Olsen, K Wachtell, C Tuxen, E Fossum, LE … - Journal of hypertension, 2005 - journals.lww.com Background: Secretion of natriuretic peptides is related to cardiac wall stress
and influenced by the renin-angiotensin system. Therefore, we investigated the
influence of blood pressure (BP) reduction with losartan versus atenolol on ... Cited by 27 - Related articles - All 4 versions
TD Szucs, M Burnier, P Erne - Cardiovascular Drugs and Therapy, 2004 - Springer Cardiovascular Drugs and Therapy 18 391–397 2004 C 2005 Springer Science +
Business Media, Inc. Manufactured in The Netherlands ... Cost-Effectiveness of
Losartan Versus Atenolol in Treating ... Hypertension—An Analysis of ... Cited by 11 - Related articles - All 6 versions
- ►zhaoys.com [PDF] SE Kjeldsen, B Dahlof, RB Devereux, S Julius … - Jama, 2002 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 268 - Related articles - BL Direct - All 9 versions
- ►oxfordjournals.org FH Messerli - European heart journal, 2003 - Eur Soc Cardiology In the LIFE study, the most recent landmark trial in hypertension, 1–3 more
than 9000 hypertensive patients were randomized to either a losartan-based
regimen or to an atenolol-based regimen. Although less than 10% of all ... Cited by 12 - Related articles - BL Direct - All 3 versions
